/
RSS Feed
SOHO Insider lymphoma podcast host Megan Melody, MD, an assistant professor at the University of South Florida and lymphoma and chimeric antigen receptor T-cell therapy specialist at Tampa General Hospital Cancer Institute interviews Anca Prica, MD, of Princess Margaret Cancer Centre, in this podcast episode.
The pair discuss Dr. Prica’s paper on glofitamab and polatuzumab for refractory Burkitt’s lymphoma, which was published in The New England Journal of Medicine earlier in 2025.
